Table 1 Prevalence of gastric carcinoma (GC) metastasis during follow-up in patients in different risk groups
GC metastasis rate (%) | OR (95% CI), high vs. low & moderate risk groups | |||
|---|---|---|---|---|
Patients in the low & moderate risk groups | Patients in the high risk group | Univariate analysis | Multivariate analysis | |
Sex | ||||
Male | 7/75 (9.3) | 13/46 (28.3) | 3.83 (1.40–10.49) | 5.38 (1.74–16.68) |
Female | 3/38 (7.9) | 3/14 (21.4) | 3.18 (0.56–18.09) | |
Age (yrs) | ||||
<60 | 4/49 (8.2) | 13/34 (38.2) | 6.96 (2.03–23.94) | 9.81 (2.50–38.46) |
≥60 | 6/64 (9.4) | 3/26 (11.5) | 1.26 (0.29–5.47) | |
Location | ||||
Non-cardiac | 6/82 (7.3) | 8/33 (24.2) | 4.05 (1.28–12.81) | 5.08 (1.51–17.06) |
Cardiac | 4/31 (12.9) | 8/27 (29.6) | 2.84 (0.75–10.81) | |
Different. | ||||
Well/ Mod. | 3/42 (7.1) | 7/20 (35.0) | 7.00 (1.58–31.09) | |
Poor | 7/69 (10.1) | 8/36 (22.2) | 2.53 (0.84–7.67) | |
Vessel embolus | ||||
Negative | 7/94 (7.4) | 12/49 (24.5) | 4.03 (1.47–11.05) | 4.13 (1.50–11.40) |
Positive | 2/18 (11.1) | 3/9 (33.3) | 6.40 (0.89–45.99) | |
TNM Stage | ||||
I | 1/34 (2.9) | 3/17 (17.6) | 7.07 (0.68–73.99) | |
II | 8/65 (12.3) | 11/35 (31.4) | 3.27 (1.17–9.13) | 4.71 (1.55–14.38) |
III | 1/14 (7.1) | 2/8 (25.0) | 4.33 (0.33–57.65) | |
Chemotherapy | ||||
No | 3/64 (4.7) | 7/33 (21.2) | 5.47 (1.31–22.84) | 5.22 (1.20–22.62) |
Yes | 6/46 (13.0) | 9/27 (33.3) | 3.78 (1.09–13.14) | 4.80 (1.30–17.78) |
(Total) | 10/113 (8.8) | 16/60 (26.7) | 3.75 (1.58–8.90) | 4.71 (1.85–12.00) |
